Worse Survival Observed Among Patients Diagnosed with Cancer During the First 2 Years of the COVID-19 Pandemic By Ogkologos - February 16, 2026 277 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the US cohort study Source RELATED ARTICLESMORE FROM AUTHOR Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant MOST POPULAR Ενθαρρυντικά δεδομένα για ασθενείς με προχωρημένο μελάνωμα που έλαβαν θεραπεία με... June 24, 2019 Contact X-ray Brachytherapy Dose Escalation Increases the Organ Preservation Rate in... November 29, 2024 Help Desk for Oncologists Treating People with a Rare Leukemia Pays... February 2, 2023 FDA Grants Accelerated Approval to Lisocabtagene Maraleucel for Follicular Lymphoma June 3, 2024 Load more HOT NEWS Dad Is Making Baby Giggle, But When He Makes A Sheep... Introducing our new podcast for researchers Final Results of the Collaborative EORTC/Intergroup Randomised Phase III Study of... Reused, Reheated Cooking Oil May Trigger Breast Cancer Progression, Metastasis